In the SURPASS clinical trial program evaluating tirzepatide for type 2 diabetes and the SURMOUNT trials for weight management, insomnia was not identified as a statistically significant adverse event compared to placebo groups, based on published trial results
Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
In 2017, when the FDA approved weekly shots for diabetes, and again in 2021, when the drug was popularized as a weight-loss treatment and patients started asking for Wegovy, Cepbound and Ozempic
Washington, U.S.A.), immunoreactivity densities of Cas-3, NF-B and AMH were determined
Many people find that the initial side effects have started to fade by now